NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 86 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $167,000 | -61.0% | 88,594 | 0.0% | 0.00% | – |
Q4 2021 | $428,000 | -33.2% | 88,594 | 0.0% | 0.00% | – |
Q3 2021 | $641,000 | -21.6% | 88,594 | 0.0% | 0.00% | – |
Q2 2021 | $818,000 | -19.6% | 88,594 | +7.3% | 0.00% | – |
Q1 2021 | $1,017,000 | -6.0% | 82,562 | +7.6% | 0.00% | – |
Q4 2020 | $1,082,000 | +17.2% | 76,713 | -0.2% | 0.00% | – |
Q3 2020 | $923,000 | -24.8% | 76,860 | +3.9% | 0.00% | -100.0% |
Q2 2020 | $1,228,000 | +667.5% | 73,959 | +426.1% | 0.00% | – |
Q1 2020 | $160,000 | -8.0% | 14,057 | 0.0% | 0.00% | – |
Q4 2019 | $174,000 | – | 14,057 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,156,200 | $10,672,000 | 1.77% |
ACT CAPITAL MANAGEMENT, LLC | 239,000 | $2,207,000 | 1.13% |
EcoR1 Capital, LLC | 2,358,804 | $21,772,000 | 0.81% |
Redmile Group, LLC | 3,919,235 | $36,175,000 | 0.54% |
Boxer Capital, LLC | 1,501,058 | $13,855,000 | 0.49% |
Baker Brothers Advisors | 3,821,740 | $35,275,000 | 0.16% |
Sio Capital Management, LLC | 38,312 | $354,000 | 0.09% |
Highland Private Wealth Management | 46,999 | $434,000 | 0.06% |
PERSONAL CFO SOLUTIONS, LLC | 23,710 | $219,000 | 0.04% |
Point72 Asset Management, L.P. | 883,102 | $8,151,000 | 0.04% |